Valuation: Amgen Inc.

Market Cap 195B 171B 158B 147B 277B 18,573B 283B 1,896B 735B 9,103B 732B 716B 31,704B P/E 2026 *
23.5x
P/E 2027 * 21.7x
Enterprise Value 237B 208B 192B 178B 337B 22,545B 343B 2,301B 892B 11,050B 889B 869B 38,484B EV / Sales 2026 *
6.27x
EV / Sales 2027 * 5.97x
Free-Float
99.78%
Yield 2026 *
2.79%
Yield 2027 * 2.95%
1 day-0.22%
1 week+4.13%
Current month-0.22%
1 month+7.29%
3 months+2.69%
6 months+10.39%
Current year+10.39%
1 week 350.06
Extreme 350.06
364
1 month 322.3
Extreme 322.3
364
Current year 318.21
Extreme 318.21
391.29
1 year 269.77
Extreme 269.77
391.29
3 years 218.44
Extreme 218.44
391.29
5 years 198.64
Extreme 198.64
391.29
10 years 133.64
Extreme 133.64
391.29
Manager TitleAgeSince
Chief Executive Officer 63 2012-04-30
Director of Finance/CFO 62 2010-05-12
Director of Finance/CFO 67 2019-12-31
Director TitleAgeSince
Chairman 63 2012-12-31
Director/Board Member 65 2011-12-31
Director/Board Member 71 2011-12-31
Date Insider Type Main position Quantity % Market Cap.
May. 18Free

Director

665 0.0001%
May. 18Free

Director

665 0.0001%
May. 18Free

Director

665 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-0.22%+4.13%+29.41%+62.75% 195B
-0.64%+7.65%+52.88%+154.11% 1,070B
+0.00%+6.23%+66.27%+53.44% 611B
-0.23%+6.94%+35.25%+86.34% 445B
+0.83%+4.18%+31.11%+23.88% 329B
-1.74%+1.94%+36.90%+22.86% 290B
-1.25%+1.28%+29.98%+38.89% 287B
+2.99%+5.28%-26.30%-41.06% 213B
-0.29%+0.74%+13.62%+63.45% 157B
-0.83%-3.40%-1.49%-34.90% 137B
Average +0.03%+4.26%+26.76%+42.98% 373.35B
Weighted average by Cap. -0.05%+6.32%+38.67%+72.38%

Financials

2026 *2027 *
Net sales 37.76B 33.19B 30.56B 28.44B 53.7B 3,596B 54.79B 367B 142B 1,763B 142B 139B 6,139B 38.71B 34.02B 31.33B 29.15B 55.05B 3,687B 56.17B 376B 146B 1,807B 145B 142B 6,294B
Net income 8.23B 7.23B 6.66B 6.2B 11.7B 784B 11.94B 80.03B 31.02B 384B 30.91B 30.23B 1,338B 8.86B 7.79B 7.17B 6.68B 12.61B 844B 12.86B 86.19B 33.4B 414B 33.29B 32.56B 1,441B
Net Debt 41.7B 36.65B 33.75B 31.41B 59.3B 3,972B 60.51B 405B 157B 1,947B 157B 153B 6,780B 36.06B 31.69B 29.18B 27.15B 51.27B 3,434B 52.32B 351B 136B 1,683B 135B 132B 5,862B
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Date Price Change Volume
26-07-01 $361.33 -0.22% 2,244,170
26-06-30 $362.12 +0.44% 2,246,908
26-06-29 $360.55 +0.62% 2,461,887
26-06-26 $358.33 +1.56% 3,610,561
26-06-25 $352.82 +0.40% 2,341,847
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
34
Last Close Price
361.33USD
Average target price
354.76USD
Spread / Average Target
-1.82%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMGN Stock